Technical Analysis for HYPR - Hyperfine, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 20 DMA | Bearish | 0.00% | |
20 DMA Support | Bullish | -2.86% | |
Gapped Down | Weakness | -2.86% | |
50 DMA Resistance | Bearish | -7.07% | |
Gapped Up | Strength | -7.07% | |
50 DMA Resistance | Bearish | -3.68% | |
Upper Bollinger Band Walk | Strength | -3.68% | |
Gapped Up | Strength | -3.68% | |
Upper Bollinger Band Touch | Strength | -3.68% | |
NR7 | Range Contraction | -4.89% |
Alert | Time |
---|---|
Possible NR7 | 2 days ago |
Possible Inside Day | 2 days ago |
Down 2 % | 2 days ago |
60 Minute Opening Range Breakdown | 2 days ago |
20 DMA Resistance | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine's portable Swoop™ system is the world's first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.28 |
52 Week Low | 0.7613 |
Average Volume | 95,536 |
200-Day Moving Average | 1.29 |
50-Day Moving Average | 0.90 |
20-Day Moving Average | 0.85 |
10-Day Moving Average | 0.88 |
Average True Range | 0.08 |
RSI (14) | 44.44 |
ADX | 19.8 |
+DI | 17.58 |
-DI | 13.15 |
Chandelier Exit (Long, 3 ATRs) | 0.78 |
Chandelier Exit (Short, 3 ATRs) | 1.01 |
Upper Bollinger Bands | 0.93 |
Lower Bollinger Band | 0.77 |
Percent B (%b) | 0.41 |
BandWidth | 18.75 |
MACD Line | -0.01 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.0048 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.96 | ||||
Resistance 3 (R3) | 0.96 | 0.93 | 0.94 | ||
Resistance 2 (R2) | 0.93 | 0.90 | 0.93 | 0.93 | |
Resistance 1 (R1) | 0.88 | 0.88 | 0.87 | 0.88 | 0.92 |
Pivot Point | 0.85 | 0.85 | 0.84 | 0.85 | 0.85 |
Support 1 (S1) | 0.80 | 0.82 | 0.79 | 0.80 | 0.75 |
Support 2 (S2) | 0.77 | 0.80 | 0.77 | 0.74 | |
Support 3 (S3) | 0.72 | 0.77 | 0.74 | ||
Support 4 (S4) | 0.72 |